- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
- Avacta to Present at Leerink Healthcare Conference
- Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
- Avacta announces data update for AVA6000
- Avacta to sell Launch Diagnostics
- Appointment of Joint Broker
- Issue of Equity and Total Voting Rights
- Avacta Announces Data from AVA6000 Phase 1 trial
- Avacta Appoints Chief Financial Officer
- Completion of Dose Escalation and RDE Arms
More ▼
Key statistics
On Monday, Avacta Group PLC (AVCT:LSE) closed at 39.00, 25.60% above the 52 week low of 31.05 set on Mar 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.50 |
---|---|
High | 39.00 |
Low | 35.80 |
Bid | -- |
Offer | -- |
Previous close | 36.50 |
Average volume | 4.01m |
---|---|
Shares outstanding | 376.22m |
Free float | 250.05m |
P/E (TTM) | -- |
Market cap | 137.32m GBP |
EPS (TTM) | -0.0867 GBP |
Data delayed at least 20 minutes, as of Mar 10 2025 17:08 BST.
More ▼